Solazyme (SZYM +9%) soars after reporting a smaller-than-expected Q1 loss and the biofuels...

Solazyme (SZYM +9%) soars after reporting a smaller-than-expected Q1 loss and the biofuels company says it's on track to begin commercial production by early 2014 and reach full capacity in 12-18 months - "unquestionably the first player in the algae arena to claim such a feat," praises Raymond James' Pavel Molchanov.

From other sites
Comments (5)
  • The Aristos
    , contributor
    Comments (58) | Send Message
    $SZYM may have finally broke out now. Looking very nice.
    9 May 2013, 03:44 PM Reply Like
  • skrauth
    , contributor
    Comments (113) | Send Message
    Y E S ! ! ! ! !
    9 May 2013, 05:37 PM Reply Like
  • chudzikb
    , contributor
    Comments (1967) | Send Message
    Patience young Jedi's...
    9 May 2013, 06:18 PM Reply Like
  • PJafferyAnalyst45
    , contributor
    Comments (81) | Send Message
    We all seen this story before. SYZM will pop to $12-$14/share, then go back down to $7-$8/share.
    9 May 2013, 09:41 PM Reply Like
  • bberuch
    , contributor
    Comments (314) | Send Message
    szym has been adding quality partners, getting closer to good scale production, and adding to well chosen potential product lines.


    doubled holdings as part of personal long term planning for my portfolio.
    13 May 2013, 10:02 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs